| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
|
Biol Blood Marrow Transplant
|
2005
|
19.83
|
|
2
|
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.
|
N Engl J Med
|
2009
|
4.97
|
|
3
|
Early-onset stroke and vasculopathy associated with mutations in ADA2.
|
N Engl J Med
|
2014
|
4.70
|
|
4
|
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.
|
Biol Blood Marrow Transplant
|
2006
|
4.09
|
|
5
|
Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.
|
Blood
|
2009
|
3.00
|
|
6
|
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
|
Blood
|
2013
|
2.82
|
|
7
|
Keratoacanthomas associated with sorafenib therapy.
|
J Am Acad Dermatol
|
2007
|
1.89
|
|
8
|
Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease.
|
Blood
|
2011
|
1.83
|
|
9
|
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor.
|
Blood
|
2014
|
1.66
|
|
10
|
A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.
|
Biol Blood Marrow Transplant
|
2011
|
1.54
|
|
11
|
Chronic granulomatous disease as a risk factor for autoimmune disease.
|
J Allergy Clin Immunol
|
2008
|
1.51
|
|
12
|
Hypomorphic Rag mutations can cause destructive midline granulomatous disease.
|
Blood
|
2010
|
1.47
|
|
13
|
Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity.
|
Arch Dermatol
|
2010
|
1.43
|
|
14
|
Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene.
|
Am J Pathol
|
2008
|
1.24
|
|
15
|
Dyskeratosis congenita: the first NIH clinical research workshop.
|
Pediatr Blood Cancer
|
2009
|
1.22
|
|
16
|
National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
|
Biol Blood Marrow Transplant
|
2013
|
1.18
|
|
17
|
Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae.
|
Arch Dermatol
|
2009
|
1.15
|
|
18
|
Cutaneous manifestations of DOCK8 deficiency syndrome.
|
Arch Dermatol
|
2011
|
1.14
|
|
19
|
Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.
|
J Allergy Clin Immunol
|
2011
|
1.08
|
|
20
|
Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.
|
Biol Blood Marrow Transplant
|
2010
|
1.05
|
|
21
|
Skin reactions in a subset of patients with stage IV melanoma treated with anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody as a single agent.
|
Arch Dermatol
|
2006
|
1.05
|
|
22
|
Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease.
|
J Am Acad Dermatol
|
2012
|
1.03
|
|
23
|
Autoinflammatory pustular neutrophilic diseases.
|
Dermatol Clin
|
2013
|
0.97
|
|
24
|
Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.
|
Hum Mol Genet
|
2013
|
0.96
|
|
25
|
Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses.
|
Arch Dermatol
|
2011
|
0.96
|
|
26
|
Multiple painful cutaneous nodules and renal mass.
|
J Am Acad Dermatol
|
2006
|
0.93
|
|
27
|
Detection of molluscum contagiosum virus (MCV) DNA in the plasma of an immunocompromised patient and possible reduction of MCV DNA with CMX-001.
|
J Infect Dis
|
2012
|
0.91
|
|
28
|
The isomorphic response in morphealike chronic graft-vs-host disease.
|
Arch Dermatol
|
2008
|
0.90
|
|
29
|
Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.
|
Biol Blood Marrow Transplant
|
2009
|
0.88
|
|
30
|
Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy.
|
Pediatr Infect Dis J
|
2008
|
0.87
|
|
31
|
Skin ulcers and disseminated abscesses are characteristic of Serratia marcescens infection in older patients with chronic granulomatous disease.
|
J Allergy Clin Immunol
|
2009
|
0.86
|
|
32
|
Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease.
|
J Am Acad Dermatol
|
2012
|
0.85
|
|
33
|
DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name?
|
Arch Dermatol
|
2012
|
0.84
|
|
34
|
Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.
|
PLoS One
|
2012
|
0.84
|
|
35
|
Gynecomastia and mucosal lentigines in an 8-year-old boy.
|
J Am Acad Dermatol
|
2005
|
0.83
|
|
36
|
Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases?
|
J Am Acad Dermatol
|
2008
|
0.81
|
|
37
|
Autoinflammation: From monogenic syndromes to common skin diseases.
|
J Am Acad Dermatol
|
2013
|
0.81
|
|
38
|
An Amish boy with recurrent ulcerations of the lower extremities, telangiectases of the hands, and chronic lung disease.
|
J Am Acad Dermatol
|
2010
|
0.80
|
|
39
|
Tyrosine kinase inhibitors directed against the vascular endothelial growth factor receptor (VEGFR) have distinct cutaneous toxicity profiles: a meta-analysis and review of the literature.
|
Support Care Cancer
|
2014
|
0.79
|
|
40
|
Proteomic patterns for classification of ovarian cancer and CTCL serum samples utilizing peak pairs indicative of post-translational modifications.
|
Proteomics
|
2007
|
0.78
|
|
41
|
Insulin resistance, acanthosis nigricans, and hypertriglyceridemia.
|
J Am Acad Dermatol
|
2005
|
0.78
|
|
42
|
Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
|
Am J Hematol
|
2014
|
0.77
|
|
43
|
Voriconazole-associated phototoxic effects and lentigo formation in an African American man.
|
Arch Dermatol
|
2012
|
0.77
|
|
44
|
Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome.
|
Blood
|
2013
|
0.77
|
|
45
|
Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease.
|
Arch Dermatol
|
2009
|
0.77
|
|
46
|
Prevalence of isolated joint involvement in chronic graft-versus-host disease: comment on the article by Inamoto et al.
|
Arthritis Rheumatol
|
2014
|
0.77
|
|
47
|
Cutaneous graft-versus-host disease--clinical considerations and management.
|
Curr Probl Dermatol
|
2012
|
0.76
|
|
48
|
Diffuse pain, hypophosphatemia, and a subcutaneous nodule.
|
J Am Acad Dermatol
|
2007
|
0.76
|
|
49
|
Diabetes insipidus, bone lesions, and new-onset red-brown papules in a 42-year-old man.
|
J Am Acad Dermatol
|
2013
|
0.75
|
|
50
|
Rippled skin, fasciitis, and joint contractures.
|
J Am Acad Dermatol
|
2008
|
0.75
|
|
51
|
Multiple angiofibromas and collagenomas in a 45-year-old man with recurrent nephrolithiasis, fatigue, and vision loss.
|
J Am Acad Dermatol
|
2009
|
0.75
|
|
52
|
Sixty-year-old man with slowly expanding nodular plaque on the thigh.
|
J Am Acad Dermatol
|
2010
|
0.75
|
|
53
|
Erythema multiforme major following treatment with infliximab.
|
Oral Surg Oral Med Oral Pathol Oral Radiol
|
2012
|
0.75
|
|
54
|
A call for more dermatologic input into chronic graft-vs-host disease clinical trials.
|
Arch Dermatol
|
2009
|
0.75
|
|
55
|
A recurrent rash with fever and arthropathy.
|
J Am Acad Dermatol
|
2006
|
0.75
|
|
56
|
Thrombocytopenia, multiple mucosal squamous cell carcinomas, and dyspigmentation.
|
J Am Acad Dermatol
|
2006
|
0.75
|
|
57
|
A Sri Lankan woman with rheumatoid arthritis and anesthetic plaques.
|
J Am Acad Dermatol
|
2009
|
0.75
|
|
58
|
Blue pigmentation and arthritis in an elderly man.
|
J Am Acad Dermatol
|
2005
|
0.75
|
|
59
|
Erratum to "Salivary Gland Involvement in Chronic Graft-versus-Host Disease: Prevalence, Clinical Significance, and Recommendations for Evaluation" [Biol Blood Marrow Transplant 16:1362-1369].
|
Biol Blood Marrow Transplant
|
2015
|
0.75
|
|
60
|
Adult T-cell leukemia-lymphoma associated with follicular mucinosis.
|
Am J Dermatopathol
|
2014
|
0.75
|
|
61
|
Luxation of the eyeball.
|
J Am Acad Dermatol
|
2004
|
0.75
|